79 related articles for article (PubMed ID: 5729491)
1. [On the frequency of sites of metastasis of malignant tumors of the ovaries (according to autopsy data from the N. N. Petrov Oncologic Institute of the MH of the USSR from 1926-1966].
Chen-Maĭransaeva TP
Vopr Onkol; 1968; 14(11):86-92. PubMed ID: 5729491
[No Abstract] [Full Text] [Related]
2. [The clinical picture and results of treating patients with ovarian fibromas (according to findings of the Prof. N.N. Petrov Research Institute of Oncology of the USSR Ministry of Health)].
Sedova TI
Vopr Onkol; 1976; 22(3):83-8. PubMed ID: 936532
[TBL] [Abstract][Full Text] [Related]
3. [Therapeutic methods in malignant tumors of the ovaries at the Prof. N.N. Petrov Scientific Research Institute of Oncology].
Nechaeva ID; Kotova DG; Vinokurov VL
Sov Med; 1977 Aug; (8):62-7. PubMed ID: 918744
[No Abstract] [Full Text] [Related]
4. Lymphatic mapping and sentinel node identification as related to the primary sites of lymph node metastasis in early stage ovarian cancer.
Negishi H; Takeda M; Fujimoto T; Todo Y; Ebina Y; Watari H; Yamamoto R; Minakami H; Sakuragi N
Gynecol Oncol; 2004 Jul; 94(1):161-6. PubMed ID: 15262135
[TBL] [Abstract][Full Text] [Related]
5. [Visceral metastasis in 135 cases of breast cancer: evaluation at autopsy].
Nakamura T; Sakamoto G; Kitagawa T; Kasuga T; Sugano H
Gan No Rinsho; 1983 Dec; 29(15):1717-20. PubMed ID: 6668670
[TBL] [Abstract][Full Text] [Related]
6. Clinical implications of metastases to the ovary.
Fujiwara K; Ohishi Y; Koike H; Sawada S; Moriya T; Kohno I
Gynecol Oncol; 1995 Oct; 59(1):124-8. PubMed ID: 7557597
[TBL] [Abstract][Full Text] [Related]
7. [Analysis of the autopsy data on those dying of ovarian carcinoma at the Institute of Oncology in the last 25 years (1955-1979)].
Stepanov V
Akush Ginekol (Sofiia); 1984; 23(6):515-20. PubMed ID: 6532231
[No Abstract] [Full Text] [Related]
8. Molecular genetic evidence of an independent origin of serous low malignant potential implants and lymph node inclusions.
Emerson RE; Wang M; Liu F; Lawrence WD; Abdul-Karim FW; Cheng L
Int J Gynecol Pathol; 2007 Oct; 26(4):387-94. PubMed ID: 17885488
[TBL] [Abstract][Full Text] [Related]
9. Suppressive role of the metastasis-related nm23-H1 gene in human ovarian carcinomas: association of high messenger RNA expression with lack of lymph node metastasis.
Viel A; Dall'Agnese L; Canzonieri V; Sopracordevole F; Capozzi E; Carbone A; Visentin MC; Boiocchi M
Cancer Res; 1995 Jun; 55(12):2645-50. PubMed ID: 7780979
[TBL] [Abstract][Full Text] [Related]
10. Surgical staging of ovarian low malignant potential tumors.
Rao GG; Skinner E; Gehrig PA; Duska LR; Coleman RL; Schorge JO
Obstet Gynecol; 2004 Aug; 104(2):261-6. PubMed ID: 15291997
[TBL] [Abstract][Full Text] [Related]
11. Splenic metastases in a large unselected autopsy series.
Schön CA; Görg C; Ramaswamy A; Barth PJ
Pathol Res Pract; 2006; 202(5):351-6. PubMed ID: 16488085
[TBL] [Abstract][Full Text] [Related]
12. [Apropos of 6 carcinoid tumors, 3 secreting].
Guivarc'h M; Voinchet O; Mouchet A
Mem Acad Chir (Paris); 1969; 95(1):77-86. PubMed ID: 5790871
[No Abstract] [Full Text] [Related]
13. [Expression of KiSS-1, matrix metalloproteinase-9, nuclear factor-kappaBp65 in ovarian tumour].
Gao GL; Liu LD; Zou XS; Chen WX
Zhonghua Fu Chan Ke Za Zhi; 2007 Jan; 42(1):34-8. PubMed ID: 17331419
[TBL] [Abstract][Full Text] [Related]
14. [Oncologic properties of non-inbred white rats raised at the Petrov Research Institute of the Ministry of Health of the USSR].
Pliss GB; Iogannsen MG; Romanov AN; Romanov KP
Vopr Onkol; 1982; 28(12):75-81. PubMed ID: 7179849
[TBL] [Abstract][Full Text] [Related]
15. [Diagnostic difficulties in serous "borderline" tumors of the ovary].
Vereczkey I; Tóth E; Orosz Z
Magy Onkol; 2009 Mar; 53(1):23-31. PubMed ID: 19318323
[TBL] [Abstract][Full Text] [Related]
16. [Long-term therapeutic results and causes of death in malignant ovarian tumors].
Wei YH
Zhonghua Zhong Liu Za Zhi; 1984 Nov; 6(6):459-61. PubMed ID: 6532753
[No Abstract] [Full Text] [Related]
17. [Radiotherapeutic results in case of malignant ovarian tumors with special consideration of stage Ia (author's transl)].
Hackl A; Schneider GH
Strahlentherapie; 1981 Dec; 157(12):780-5. PubMed ID: 7330905
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of lymph node metastasis and clear cell histology in ovarian carcinoma limited to the pelvis (pT1M0 and pT2M0).
Sakuragi N; Yamada H; Oikawa M; Okuyama K; Fujino T; Sagawa T; Fujimoto S
Gynecol Oncol; 2000 Nov; 79(2):251-5. PubMed ID: 11063653
[TBL] [Abstract][Full Text] [Related]
19. B7-H4 overexpression in ovarian tumors.
Tringler B; Liu W; Corral L; Torkko KC; Enomoto T; Davidson S; Lucia MS; Heinz DE; Papkoff J; Shroyer KR
Gynecol Oncol; 2006 Jan; 100(1):44-52. PubMed ID: 16256178
[TBL] [Abstract][Full Text] [Related]
20. Retrograde lymphatic spread: a likely route for metastatic ovarian cancers of gastrointestinal origin.
Chang TC; Changchien CC; Tseng CW; Lai CH; Tseng CJ; Lin SE; Wang CS; Huang KJ; Chou HH; Ma YY; Hsueh S; Eng HL; Fan HA
Gynecol Oncol; 1997 Sep; 66(3):372-7. PubMed ID: 9299248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
